Survival estimates of outcome after reduced-intensity allogeneic SCT according to pretransplantation PET status. All lymphoma subtypes are shown (percentages on the graphs indicate 3-year rates for each outcome). (A) OS. (B) Nonrelapse mortality. (C) Relapse and primary progression. (D) PFS. (E) cPFS.